GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,461,000 | -25.6% | 953,396 | -19.4% | 6.97% | -28.0% |
| Q1 2022 | $40,955,000 | +88.3% | 1,182,307 | +59.1% | 9.68% | +35.1% |
| Q4 2021 | $21,748,000 | +241.4% | 743,000 | +197.2% | 7.17% | +209.6% |
| Q3 2021 | $6,370,000 | -13.4% | 250,000 | +19.0% | 2.32% | -23.4% |
| Q2 2021 | $7,354,000 | +3.1% | 210,000 | +20.0% | 3.02% | +0.6% |
| Q1 2021 | $7,131,000 | -23.4% | 175,000 | -18.6% | 3.01% | -9.7% |
| Q4 2020 | $9,312,000 | – | 215,000 | – | 3.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |